|
|
Defining the Optimal Therapeutic Sequence for Patients With NSCLC: Molecular and Clinical Considerations
Chair[s]: H. Jack West, MD
Critical Updates in the Treatment of Non–Small Cell Lung Cancer
Chair[s]: Anne Tsao, MD, Mark A. Socinski, Guest Editor
|
|
The Emerging Role of Epothilones in Treating Resistant/Refractory Metastatic Breast Cancer
Chair[s]:
Howard J. Burstein, MD, PhD
Case 1:
Case 2:
Maximizing Treatment Benefits for Your Patients With Colorectal Cancer: Current Concepts and Unanswered Questions
Chair[s]:
John Marshal, MD
Case 1:
Case 2:
Progress and Challenges in the Management of Patients With Iron Overload
Chair[s]:
Ellis J. Neufeld, MD, PhD
Case 1:
Management of Poor-Risk Patients With Non-Small Cell Lung Cancer
Chair[s]:
H. Jack West, MD
Case 1:
Case 2:
Case 3:
Case 4:
Case 5:
Case 6:
Click here for details
|